Walleye Trading
RIGL icon

Walleye Trading’s Rigel Pharmaceuticals RIGL Stock Holding History

Walleye Trading’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,500
Closed -$27K – 4526
2020
Q2 		$27K Buy
+1,500
New +$27K ﹤0.01% 3936
2018
Q4 		– Sell
-23,366
Closed -$750K – 5196
2018
Q3 		$750K Buy
23,366
+2,739
+13% +$82.2K ﹤0.01% 2427
2018
Q2 		$584K Buy
+20,627
New +$734K ﹤0.01% 2686
2017
Q2 		– Sell
-600
Closed -$20 – 4871
2017
Q1 		$20 Buy
+600
New +$15.3K ﹤0.01% 4131
2016
Q1 		– Sell
-1,190
Closed -$36K – 5757
2015
Q4 		$36K Sell
1,190
-840
-41% -$25.5K ﹤0.01% 4080
2015
Q3 		$50K Buy
2,030
+1,970
+3,283% +$58.8K ﹤0.01% 3505
2015
Q2 		$2K Buy
+60
New +$2.29K ﹤0.01% 4675

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's RIGL Position: Q3 2020 in Review

Walleye Trading sold out of Rigel Pharmaceuticals (RIGL) in Q3 2020, closing a stake of 1,500 shares — an estimated $27K sold.

Walleye Trading first reported a position in RIGL in Q2 2015 and held it in 7 quarters. The position peaked at $750K in Q3 2018. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2020.

  • Walleye Trading reported no remaining Rigel Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Walleye Trading sold 1,500 Rigel Pharmaceuticals shares in Q3 2020, an estimated $27K.
  • Walleye Trading first reported a position in Rigel Pharmaceuticals in Q2 2015 and held it in 7 quarters.
  • Walleye Trading's Rigel Pharmaceuticals position peaked at $750K in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.